BRPI0608395A2 - composição farmacêutica sólida que compreende telitromicina - Google Patents
composição farmacêutica sólida que compreende telitromicinaInfo
- Publication number
- BRPI0608395A2 BRPI0608395A2 BRPI0608395-1A BRPI0608395A BRPI0608395A2 BR PI0608395 A2 BRPI0608395 A2 BR PI0608395A2 BR PI0608395 A BRPI0608395 A BR PI0608395A BR PI0608395 A2 BRPI0608395 A2 BR PI0608395A2
- Authority
- BR
- Brazil
- Prior art keywords
- telithromycin
- pharmaceutical composition
- solid pharmaceutical
- weight
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
COMPOSIçãO FARMACêUTICA SóLIDA QUE COMPREENDE TELITROMICINA. A patente de invenção refere-se a uma composição farmacêutica sól ida que compreende telitromicina ou um de seus sais de adição com um ácido farmaceuticamente aceitável, como princípio ativo, caracterizada pelo fato de que ela compreende, em relação ao peso total da composição: telitromicina ou um de seus sais de adição com um ácido farmaceuticamente aceitável, de acordo com uma proporção em telitromicina compreendida entre 0,1 e 80 % em peso, e pelo menos um agente diluente de comportamento plástico, de acordo com uma proporção de 10 a 50 % em peso. A presente invenção provê vantajosamente um comprimido de telitromicina tendo um tamanho sensivelmente reduzido, porém com dosagem igual de telitromicina, e apresentando propriedades mecânicas melhoradas.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0501936A FR2882522B1 (fr) | 2005-02-25 | 2005-02-25 | Composition pharmaceutique solide comprenant de la telithromycine |
| PCT/FR2006/000411 WO2006090067A1 (fr) | 2005-02-25 | 2006-02-23 | Composition pharmaceutique solide comprenant de la telithromycine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0608395A2 true BRPI0608395A2 (pt) | 2009-12-29 |
Family
ID=35106715
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0608395-1A BRPI0608395A2 (pt) | 2005-02-25 | 2006-02-23 | composição farmacêutica sólida que compreende telitromicina |
Country Status (29)
| Country | Link |
|---|---|
| US (2) | US20080113020A1 (pt) |
| EP (1) | EP1855695B1 (pt) |
| JP (1) | JP5063368B2 (pt) |
| KR (1) | KR101346453B1 (pt) |
| CN (1) | CN101180064B (pt) |
| AR (1) | AR053144A1 (pt) |
| AT (1) | ATE486633T1 (pt) |
| AU (1) | AU2006217814B2 (pt) |
| BR (1) | BRPI0608395A2 (pt) |
| CA (1) | CA2598210A1 (pt) |
| CY (1) | CY1111129T1 (pt) |
| DE (1) | DE602006017975D1 (pt) |
| DK (1) | DK1855695T3 (pt) |
| ES (1) | ES2354906T3 (pt) |
| FR (1) | FR2882522B1 (pt) |
| HK (1) | HK1120412A1 (pt) |
| HR (1) | HRP20110089T1 (pt) |
| IL (1) | IL185251A (pt) |
| ME (1) | ME01936B (pt) |
| MX (1) | MX2007010405A (pt) |
| MY (1) | MY145394A (pt) |
| PL (1) | PL1855695T3 (pt) |
| PT (1) | PT1855695E (pt) |
| RS (1) | RS51578B (pt) |
| RU (1) | RU2371184C2 (pt) |
| SI (1) | SI1855695T1 (pt) |
| TW (1) | TWI371280B (pt) |
| UY (1) | UY29403A1 (pt) |
| WO (1) | WO2006090067A1 (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2882522B1 (fr) | 2005-02-25 | 2007-04-13 | Aventis Pharma Sa | Composition pharmaceutique solide comprenant de la telithromycine |
| CN102499936B (zh) * | 2011-12-01 | 2013-06-26 | 西北农林科技大学 | 一种复方泰利霉素纳米乳口服液及其制备方法 |
| JP6112696B1 (ja) * | 2015-10-05 | 2017-04-12 | 富山化学工業株式会社 | ソリスロマイシンを含む錠剤 |
| WO2017122147A1 (en) * | 2016-01-12 | 2017-07-20 | Wockhardt Limited | Pharmaceutical compositions |
| WO2020021574A1 (en) * | 2018-07-27 | 2020-01-30 | Wockhardt Limited | Pharmaceutical compositions and methods |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2719587B1 (fr) | 1994-05-03 | 1996-07-12 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
| AR024353A1 (es) * | 1999-06-15 | 2002-10-02 | He Chunhong | Audifono y equipo auxiliar interactivo con relacion de voz a audio remanente |
| FR2821747B1 (fr) * | 2001-03-09 | 2004-07-02 | Ethypharm Lab Prod Ethiques | Suspension de telithromycine a gout masque |
| FR2826274B1 (fr) * | 2001-06-21 | 2003-09-26 | Aventis Pharma Sa | Formulation pharmaceutique au gout masque et son procede de preparation |
| KR100487137B1 (ko) * | 2002-07-12 | 2005-05-03 | 주식회사 하이닉스반도체 | 반도체 소자의 제조 방법 |
| WO2004009059A1 (en) * | 2002-07-19 | 2004-01-29 | Aventis Pharma S.A. | Taste masked oral composition of telithromycin |
| US20040013737A1 (en) * | 2002-07-19 | 2004-01-22 | Philippe Becourt | Taste masked oral composition of telithromycin |
| AU2003274927A1 (en) * | 2002-08-23 | 2004-03-11 | Genome Therapeutics Corporation | Methods and reagents for preventing bacteremias |
| ATE448775T1 (de) * | 2002-08-29 | 2009-12-15 | Activbiotics Pharma Llc | Rifalazil zur behandlung von infektionen mit clostridium difficile |
| GB0230034D0 (en) * | 2002-12-23 | 2003-01-29 | Biochemie Gmbh | Organic compounds |
| US20050037983A1 (en) * | 2003-03-11 | 2005-02-17 | Timothy Dinan | Compositions and methods for the treatment of depression and other affective disorders |
| JP2006522099A (ja) * | 2003-04-04 | 2006-09-28 | ファルマシア コーポレーション | 複合粒状体からなる経口徐放性圧縮錠 |
| FR2882522B1 (fr) | 2005-02-25 | 2007-04-13 | Aventis Pharma Sa | Composition pharmaceutique solide comprenant de la telithromycine |
-
2005
- 2005-02-25 FR FR0501936A patent/FR2882522B1/fr not_active Expired - Fee Related
-
2006
- 2006-02-20 MY MYPI20060710A patent/MY145394A/en unknown
- 2006-02-23 JP JP2007556635A patent/JP5063368B2/ja not_active Expired - Fee Related
- 2006-02-23 DE DE602006017975T patent/DE602006017975D1/de active Active
- 2006-02-23 AU AU2006217814A patent/AU2006217814B2/en not_active Ceased
- 2006-02-23 ES ES06725981T patent/ES2354906T3/es active Active
- 2006-02-23 EP EP06725981A patent/EP1855695B1/fr active Active
- 2006-02-23 MX MX2007010405A patent/MX2007010405A/es active IP Right Grant
- 2006-02-23 WO PCT/FR2006/000411 patent/WO2006090067A1/fr active Application Filing
- 2006-02-23 AR ARP060100663A patent/AR053144A1/es unknown
- 2006-02-23 RU RU2007135367/15A patent/RU2371184C2/ru not_active IP Right Cessation
- 2006-02-23 PL PL06725981T patent/PL1855695T3/pl unknown
- 2006-02-23 DK DK06725981.2T patent/DK1855695T3/da active
- 2006-02-23 SI SI200630881T patent/SI1855695T1/sl unknown
- 2006-02-23 RS RS20110038A patent/RS51578B/en unknown
- 2006-02-23 AT AT06725981T patent/ATE486633T1/de active
- 2006-02-23 PT PT06725981T patent/PT1855695E/pt unknown
- 2006-02-23 CN CN200680005962XA patent/CN101180064B/zh not_active Expired - Fee Related
- 2006-02-23 BR BRPI0608395-1A patent/BRPI0608395A2/pt not_active IP Right Cessation
- 2006-02-23 CA CA002598210A patent/CA2598210A1/fr not_active Abandoned
- 2006-02-23 KR KR1020077021860A patent/KR101346453B1/ko not_active IP Right Cessation
- 2006-02-24 UY UY29403A patent/UY29403A1/es unknown
- 2006-02-24 TW TW095106185A patent/TWI371280B/zh not_active IP Right Cessation
-
2007
- 2007-08-13 IL IL185251A patent/IL185251A/en not_active IP Right Cessation
- 2007-08-16 US US11/839,719 patent/US20080113020A1/en not_active Abandoned
-
2008
- 2008-11-06 HK HK08112195.0A patent/HK1120412A1/xx not_active IP Right Cessation
-
2011
- 2011-01-21 CY CY20111100068T patent/CY1111129T1/el unknown
- 2011-02-03 HR HR20110089T patent/HRP20110089T1/hr unknown
-
2013
- 2013-08-30 US US14/014,677 patent/US8962021B2/en not_active Expired - Fee Related
-
2016
- 2016-10-19 ME MEP-2011-213A patent/ME01936B/me unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR054581A1 (es) | Composiciones farmaceuticas que comprenden levetiracetam y proceso para su preparacion | |
| BRPI0508540A (pt) | composto, composição farmacêutica, e, uso de um composto | |
| EA200870216A1 (ru) | Амидо соединения и их применение в качестве лекарственных средств | |
| TW200733968A (en) | Stabilized lanthanum carbonate compositions | |
| BR112014027116A2 (pt) | formulação de anticorpo | |
| BR112015000320A2 (pt) | composições farmacêuticas dissuasivas de abuso, de liberação prolongada | |
| BRPI0615860B8 (pt) | composição farmacêutica de liberação prolongada monolítica sólida | |
| BR112012018384A2 (pt) | composição farmacêutica sólida com intensificadores e métodos de preparação da mesma. | |
| BRPI0415121A (pt) | material particulado, forma de dosagem sólida, método para fabricar a mesma, e, uso de um material particulado ou de uma forma de dosagem sólida | |
| WO2010100200A3 (en) | Lyophilised antibody formulation | |
| CO5640037A2 (es) | Derivados de la quinazolina para el tratamiento del cancer | |
| BRPI0508833A (pt) | formulações galênicas de compostos orgánicos | |
| BRPI0413361B8 (pt) | comprimido seguro contra abuso termo-moldado por extrusão sem descoramento | |
| BRPI0518191A (pt) | métodos e composições para reduzir a toxicidade de um composto farmacêutico | |
| CL2009000573A1 (es) | Composicion farmaceutica inyectable intraocular en forma de suspension acuosa que no contiene preservante, que consiste de acetonido de triamcinolona, carboximetilcelulosa de sodio, 0,002-0,02% de polisorbato 80, cloruros para ajustar la tonicidad, agente tamponante, agua y agente de ajuste de ph; uso para tratar el ojo. | |
| BRPI0922804B8 (pt) | composição farmacêutica em uma forma de dosagem sólida compreendendo bendamustina e um excipiente farmaceuticamente aceitável | |
| BRPI0608395A2 (pt) | composição farmacêutica sólida que compreende telitromicina | |
| DE602006016127D1 (de) | Zusammensetzung und dosierform mit einer festen oder halbfesten matrix | |
| AR056835A1 (es) | Composicion que contiene oligosacaridos | |
| WO2007064620A3 (en) | Compositions comprising a combination of ccr5 and cxcr4 antagonists | |
| BRPI0916885B8 (pt) | composição farmacêutica | |
| BR0309057A (pt) | Formulações lìquidas com baixa dosagem em entecavir e uso | |
| FR2887150B1 (fr) | Composition pharmaceutique comprenant un elastomere organopolysiloxane et un principe actif solubilise | |
| BR0116060A (pt) | Composição farmacêutica de dronedarona para administração parenteral | |
| BRPI0510820A (pt) | composição farmacêutica, forma unitária de dosagem e seus usos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 11A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |